GPX4 and neoplasm: Amphiphilic polymeric micelles linked to nitroimidazole-coupled peptides via an azobenzene linker were used to load RSL3, enabling the rapid and precise release of RSL3, which was able to significantly reduce GPX4 expression, with a twofold increase in anti-tumor efficiency compared to RSL3 (51).